Search Results - "Gavish, Dov"

Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? by Shargorodsky, Marina, Omelchenko, Elena, Matas, Zipora, Boaz, Mona, Gavish, Dov

“…Insulin resistance (IR) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease…”
Get full text

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation by Dadon, Ziv, Moriel, Mady, Iakobishvili, Zaza, Asher, Elad, Samuel, Tal Y., Gavish, Dov, Glikson, Michael, Gottlieb, Shmuel

“…Constituting hypolipidemic and pleiotropic effects, statins stabilize coronary artery plaque and may prevent STEMI events. This study investigated the…”
Get full text

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations by Silverberg, Donald S, Wexler, Dov, Blum, Miriam, Keren, Gad, Sheps, David, Leibovitch, Eyal, Brosh, David, Laniado, Shlomo, Schwartz, Doron, Yachnin, Tatyana, Shapira, Itzhak, Gavish, Dov, Baruch, Ron, Koifman, Bella, Kaplan, Carl, Steinbruch, Shoshana, Iaina, Adrian

“…OBJECTIVES This study evaluated the prevalence and severity of anemia in patients with congestive heart failure (CHF) and the effect of its correction on…”
Get full text

Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease by Maccubbin, Darbie, PhD, Koren, Michael J., MD, Davidson, Michael, MD, Gavish, Dov, MD, Pasternak, Richard C., MD, Macdonell, Geraldine, MHA, Mallick, Madhuja, PhD, Sisk, Christine McCrary, BS, Paolini, John F., MD, PhD, Mitchel, Yale, MD

“…Niacin has beneficial effects on a patient's lipid and lipoprotein profiles and cardiovascular risk, particularly at doses >2 g/day, but is underused due to…”
Get full text

Hemoglobin A1C as a prognostic factor and the pre-diabetic paradox in patients admitted to a tertiary care medical center intensive cardiac care unit by Lupu, Lior, Taha, Louay, Farkash, Rivka, Bayya, Feras, Karmi, Mohammad, Steinmetz, Yoed, Fauzi Fadi Shaheen, Perel, Nimrod, Hamayel, Kamal, Levi, Nir, Maller, Tommer, Karameh, Hani, Lichewitz, Gavriel, Gavish, Dov, Algur, Nurit, Glikson, Michael

“…Background Hemoglobin A1C (HbA1c) is a form of glycated hemoglobin used to estimate glycemic control in diabetic patients. Data regarding the prognostic…”
Get full text

Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease by Omelchenko, Elena, Gavish, Dov, Shargorodsky, Marina

“…Adiponectin has recently been considered as a possible link between liver dysfunction and atherosclerosis in patients with nonalcoholic fatty liver disease…”
Get more information

Relation of Haptoglobin Phenotype to Early Vascular Changes in Patients With Diabetes Mellitus by Shor, Marina, MD, Boaz, Mona, PhD, Gavish, Dov, MD, Wainshtein, Julio, MD, Matas, Zipora, PhD, Shargorodsky, Marina, MD

“…Haptoglobin (Hp) is an antioxidant protein and the major susceptibility gene for atherosclerosis in diabetic patients. The effect of Hp phenotype on arterial…”
Get full text

Cost-utility analysis of a national project to reduce hypertension in Israel by Yosefy, Chaim, Ginsberg, Gary, Viskoper, Reuven, Dicker, Dror, Gavish, Dov

“…This study aims to calculate the health effects and costs of a proposed national hypertension prevention and control program. Interventions are based on…”
Get full text

The molecular basis of severe hypertriglyceridemia: from genetic counseling to gene therapy by Gavish, Dov

Get full text

P-12: The link between nitric oxide system and aldosterone: Long term oral supplementation of L-Arginine improves arterial elasticity and hemodynamic variables by Gutman, Hila N.M.N., Shargorodsky, Marina N.M.N., Brendeis, Rachel N.M.N., Gavish, Dov N.M.N. Dov, Zimlichman, Reuven N.M.N.

“…Background: Dietary Supplementation with L-Arginine enhances activity of the NO system. We aimed to evaluate, in a double blind placebo controlled randomized…”
Get full text

Comparison of short-term renal effects and efficacy of rosuvastatin 40 mg and simvastatin 80 mg, followed by assessment of long-term renal effects of rosuvastatin 40 mg, in patients with dyslipidemia by Stein, Evan A., MD, PhD, Marais, A. David, MBChB, FCP (SA), Ducobu, Jean, MD, Farnier, Michel, MD, PhD, Gavish, Dov, MD, Hauner, Hans, MD, Kaplan, Andrew J., MD, FACC, Le Maulf, Florence, BSc (Hons), MSc, Melezínková, Helena, MD

“…Background An open-label, randomized, multinational, parallel-group trial compared the short-term (6-week) renal effects of rosuvastatin 40 mg and simvastatin…”
Get full text

Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health by Lukich, Alla, Gavish, Dov, Shargorodsky, Marina

“…The present study investigated the impact of overall obesity defined by BMI and abdominal obesity defined by WC on vascular atherosclerotic changes in obese…”
Get full text

DIAGNOSIS AND TREATMENT OF ELEVATED LIPOPROTEIN(A) IN ISRAEL: CONSENSUS STATEMENT FROM THE ISRAEL SOCIETY FOR RESEARCH, PREVENTION AND TREATMENT OF ATHEROSCLEROSIS AND ISRAEL SOCIETY FOR CLINICAL LABORATORY SCIENCES by Zafrir, Barak, Durst, Ronen, Henig, Clara, Henkin, Yaakov, Itzhakov, Elena, Kaplan, Marielle, Gavish, Dov

“…Lipoprotein(a) [Lp(a)] is composed of 2 major protein components, a low-density lipoprotein (LDL) cholesterol-like particle containing apolipoprotein B (apo B)…”
Get more information

TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS by Cohen, Hofit, Durst, Ronen, Elis, Avishay, Gavish, Dov, Schurr, Daniel

“…Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder caused by mutations affecting the function of the LDL receptor. In the Israeli…”
Get more information

Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats by Shirin, Haim, Sharvit, Efrat, Aeed, Hussein, Gavish, Dov, Bruck, Rafael

“…To examine whether the administration of atorvastatin and rosuvastatin would prevent experimentally-induced hepatic cirrhosis in rats. Liver cirrhosis was…”
Get full text

2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP) by Banach, Maciej, Reiner, Željko, Surma, Stanisław, Bajraktari, Gani, Bielecka-Dabrowa, Agata, Bunc, Matjaz, Bytyçi, Ibadete, Ceska, Richard, Cicero, Arrigo F. G., Dudek, Dariusz, Dyrbuś, Krzysztof, Fedacko, Jan, Fras, Zlatko, Gaita, Dan, Gavish, Dov, Gierlotka, Marek, Gil, Robert, Gouni-Berthold, Ioanna, Jankowski, Piotr, Járai, Zoltán, Jóźwiak, Jacek, Katsiki, Niki, Latkovskis, Gustavs, Magda, Stefania Lucia, Margetic, Eduard, Margoczy, Roman, Mitchenko, Olena, Durak-Nalbantic, Azra, Ostadal, Petr, Paragh, Gyorgy, Petrulioniene, Zaneta, Paneni, Francesco, Pećin, Ivan, Pella, Daniel, Postadzhiyan, Arman, Stoian, Anca Pantea, Trbusic, Matias, Udroiu, Cristian Alexandru, Viigimaa, Margus, Vinereanu, Dragos, Vlachopoulos, Charalambos, Vrablik, Michal, Vulic, Dusko, Penson, Peter E.

“…Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity and mortality across…”
Get full text

Hemoglobin A1C as a prognostic factor and the pre-diabetic paradox in patients admitted to a tertiary care medical center intensive cardiac care unit : The Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-6) study group by Lupu, Lior, Taha, Louay, Farkash, Rivka, Bayya, Feras, Karmi, Mohammad, Steinmetz, Yoed, Shaheen, Fauzi Fadi, Perel, Nimrod, Hamayel, Kamal, Levi, Nir, Maller, Tommer, Karameh, Hani, Lichewitz, Gavriel, Gavish, Dov, Algur, Nurit, Glikson, Michael, Asher, Elad

“…Hemoglobin A1C (HbA1c) is a form of glycated hemoglobin used to estimate glycemic control in diabetic patients. Data regarding the prognostic significance of…”
Get full text

Childhood obesity/overweight: early diagnosis to prevent premature cardiovascular disease by Gavish, Dov

Get full text

Molecular genetics of familial hypercholesterolemia in Israel–Revisited by Durst, Ronen, Ibe, Uche Ken, Shpitzen, Shoshi, Schurr, Daniel, Eliav, Osnat, Futema, Marta, Whittall, Ros, Szalat, Auryan, Meiner, Vardiella, Knobler, Hilla, Gavish, Dov, Henkin, Yaakov, Ellis, Avishay, Rubinstein, Ardon, Harats, Dror, Bitzur, Rafael, Hershkovitz, Bruno, Humphries, Steve E, Leitersdorf, Eran

“…Abstract Background and aims Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the genes for LDL receptor ( LDLR ),…”
Get full text

Molecular genetics of familial hypercholesterolemia in Israel – revisited by Ronen, Durst, Ibe, Uche Ken, Shoshi, Shpitzen, Daniel, Schurr, Marta, Futema, Ros, Whittal, Auryan, Szalat, Hilla, Knobler, Dov, Gavish, Yaakov, Henkin, Avishay, Ellis, Ardon, Rubinstein, Dror, Harats, Rafael, Bitzur, Bruno, Hershkovit, Steve E, Humphrie, Eran, Leitersdorf, Meiner, Vardilla

Get full text